Dr. Benjamin Lockshin graduated with honors from Brandeis University with a bachelor’s degree in fine arts and sculpture. He earned his medical degree from Georgetown University in 2001 and completed his residency at Indiana University in 2005. Following his residency, he taught at Case Western University and Johns Hopkins University.
At his practice, Dr. Benjamin Lockshin specializes in medical dermatology. He is the director of the Clinical Trials Center at DermAssociates, which conducts various trials and studies in partnership within the industry and the NIH.
In addition to private practice, Dr. Benjamin Lockshin continues to be actively involved in resident education. He currently leads didactic case reviews for the residents at Georgetown University/Washington Hospital Center. His efforts were recognized with the Resident’s Teaching Award at Johns Hopkins in 2012. Dr. Ben has published numerous peer-reviewed articles and has written several chapters for dermatology textbooks. He regularly gives lectures across the country on psoriasis therapies and research.
Currently, Dr. Benjamin Lockshin is on the board of directors for the National Psoriasis Foundation (NPF) and is also the chair of the research committee for the NPF. Recently, he has been honored to join the Medical Scientific Advisory Council for the DMV Chapter of the Lupus Foundation of America.
Dr. Benjamin Lockshin is a board-certified dermatologist and a member of the American Society of Dermatologic Surgeons. He is also an active member of the Washington, D.C., Dermatological Society and has served in the past as the society’s president.
Dr. Benjamin Lockshin has been recognized as one of the Washingtonian’s top dermatologists and was voted by his peers as one of the top dermatologists in the Washington Checkbook Magazine.
Basal Cell Carcinoma, also known as basalioma or basal cell cancer, is the most common type of skin cancer and carries the least amount of risk, though it still requires attention. If caught and treated early, basal cell carcinomas are not likely to be life-threatening, but they do have the potential to cause disfigurement of the skin tissue.
Almost one million new cases of basal cell carcinoma are diagnosed each year in the U.S., and up to 30% of Caucasians may develop basal cell carcinomas in their lifetime.
Skin cancer is considered low risk when the affected cells remain clustered in a single group. Both basal cell carcinoma and squamous cell carcinoma are rarely life-threatening. Though it is unlikely to spread to other parts of your body, if left untreated, basal cell carcinoma can move into nearby bone or other tissue.
Basal cell carcinoma typically begins as a small, shiny bump on the face, although it can occur on any part of the body.
Skin cancer is the most common form of cancer in the U.S. with more than 3.5 million cases diagnosed each year.
Skin cancer is the result of uncontrolled growth of abnormal skin cells that takes place when skin cells suffer DNA damage and then mutate, causing them to multiply rapidly and form malignant (cancerous) tumors. Most skin cancers develop on the visible outer layer of the skin (the epidermis), particularly on sun-exposed areas such as the face, head, hands, arms and legs. They are usually easy to detect with a skin examination, which increases the chances of early diagnosis.
There are different types of skin cancer, each named for the type of skin cell from which they originate. The most common type of skin cancer is basal cell carcinoma. Almost one million new cases of basal cell carcinoma are diagnosed each year in the U.S. Most skin cancers fall into one of three categories:
There are often warning signs that cancer is developing. The most common are pre-cancerous lesions called actinic keratoses that often develop on sun-exposed areas. These tumors replace normal surrounding tissue and generally do not spread to other areas.
Skin cancer is considered low risk when the affected cells remain clustered in a single group. Both basal cell carcinoma and squamous cell carcinoma are rarely life-threatening.
Skin cancer is considered a high risk when cells have invaded surrounding tissues. The third most common skin cancer, malignant melanoma, can be life-threatening if not diagnosed and treated early.
If skin cancer is detected before it has spread to surrounding tissues, the chances of a complete recovery and cure are excellent. High-risk forms of cancer like melanoma require more aggressive treatments.
Squamous Cell Carcinoma is a common form of skin cancer that develops in the squamous cells that make up the outer layer of the skin. Although it is usually not life-threatening, it can be aggressive in some cases.
If left untreated, squamous cell carcinoma can grow large or spread to other parts of your body, causing serious complications.
Alopecia Areata, also known as spot baldness, is a type of hair loss in which your immune system attacks hair follicles. This leads to areas of baldness on the scalp and body. In severe cases, a person with alopecia may even lose the hair of their eyebrows and eyelashes.
If you’ve struggled with moderate to severe acne, including cystic or nodular acne, you know that many common acne treatments aren’t effective for everyone. Fortunately, the physicians at U.S. Dermatology Partners commonly prescribe Accutane (isotretinoin) for the treatment of those patients with acne that is unresponsive to other therapeutic options.
Acne is a dermatological condition caused by inflammation and mild infection in clogged pores. If not properly treated, acne can cause emotional distress, low self-esteem, and depression. In severe cases, it can even lead to permanent scarring.
While not a serious physical health threat, acne is an embarrassing skin problem that can be life-altering for many patients. Though it is most common among teenagers, acne can affect anyone, regardless of age or gender, and can be mild, moderate or severe.
Dermatitis, also sometimes referred to as eczema, is a common condition characterized by an itchy rash and inflamed skin. There are many different types of dermatitis and symptoms can range in severity from mild itching and redness to severe blistering and cracked skin.
Eczema, also sometimes referred to as dermatitis, is a common condition characterized by a certain type of inflammation in the skin. There are many different types of eczema and symptoms can range from mild itching and redness to severe blistering and cracked skin. Whether you’re newly diagnosed with eczema or you’ve struggled with this chronic skin condition for years, you know that finding a treatment that works for you isn’t just important – it’s essential. Without proper and effective interventions, people with eczema can experience significant discomfort, itching, and inflammation.
At U.S. Dermatology Partners, our knowledgeable dermatologists partner with their patients to develop and maintain an effective eczema maintenance plan and provide advanced treatments for serious flareups. Learn more on this page or contact U.S. Dermatology Partners to get started working with us today.
Psoriasis is a chronic autoimmune inflammatory condition that causes patches of skin to become red, inflamed, and bumpy. This disease affects more than 8 million people in the U.S.
Psoriasis occurs when the immune system mistakes skin cells for a virus or other infection and responds by producing more skin cell growth. This can be triggered by stress, anxiety, injuries to the skin, infections and hormonal changes.
Vitiligo is an autoimmune disease in which white patches of skin appear on different areas of the body. This happens when melanocytes, the cells that make pigment in the skin, are destroyed. In addition to the skin, it can affect the mucous membranes of the mouth and nose as well as the eyes. Its cause is not known.